Join thousands of book lovers
Sign up to our newsletter and receive discounts and inspiration for your next reading experience.
By signing up, you agree to our Privacy Policy.You can, at any time, unsubscribe from our newsletters.
Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents
- Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988
part of the Developments in Cardiovascular Medicine series
- Binding:
- Paperback
- Pages:
- 298
- Published:
- October 9, 2011
- Edition:
- 11989
- Dimensions:
- 155x235x17 mm.
- Weight:
- 492 g.
Delivery:
2-4 weeks
Expected delivery: January 24, 2025
Extended return policy to January 30, 2025
Description of Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents
Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 and 28, 1988
User ratings of Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents
Rate this book
In order to rate this book you must be logged in.Others also bought..
Find similar books
The book Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents can be found in the following categories:
You can, at any time, unsubscribe from our newsletters.
© 2024 Tales
All packages are shipped from our warehouse in the UK.
Company address: Esromgade 15, 3. - 2200 - DK
Registered company number: DK43351621
